Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy
Public ClinicalTrials.gov record NCT01782222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Multinational, Double-Blind, Placebo-Controlled, 3-Arm, Phase 4 Study To Evaluate The Efficacy Of Rotigotine On Parkinson's Disease-Associated Apathy, Motor Symptoms, And Mood
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is being conducted to assess the effects of Rotigotine over Placebo on improvement of Apathy and motor symptoms in subjects with early-stage and advanced stage idiopathic Parkinson´s Disease.
Study identification
- NCT ID
- NCT01782222
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2013 (Type not available)
- Primary completion
- Jan 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Aug 31, 2018
2013 – 2014
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 4320 | Birmingham | Alabama | — | — |
| 4309 | Oxnard | California | — | — |
| 4306 | Ormond Beach | Florida | — | — |
| 4311 | Palm Beach Gardens | Florida | — | — |
| 4313 | Tampa | Florida | — | — |
| 4314 | Decatur | Georgia | — | — |
| 4318 | Chicago | Illinois | — | — |
| 4316 | Winfield | Illinois | — | — |
| 4322 | Des Moines | Iowa | — | — |
| 4304 | Kansas City | Kansas | — | — |
| 4326 | Springfield | Massachusetts | — | — |
| 4330 | Ocean Springs | Mississippi | — | — |
| 4302 | Las Vegas | Nevada | — | — |
| 4303 | Commack | New York | — | — |
| 4317 | New York | New York | — | — |
| 4323 | New York | New York | — | — |
| 4319 | Asheville | North Carolina | — | — |
| 4325 | Charlotte | North Carolina | — | — |
| 4329 | Akron | Ohio | — | — |
| 4312 | Cincinnati | Ohio | — | — |
| 4324 | Beaufort | South Carolina | — | — |
| 4332 | Charleston | South Carolina | — | — |
| 4305 | San Antonio | Texas | — | — |
| 4307 | Salt Lake City | Utah | — | — |
| 4333 | Virginia Beach | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01782222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01782222 live on ClinicalTrials.gov.